Beone Medicines Ltd. Class A · SSE:688235

Wang Xiaodong sold 31,028 Beone Medicines Ltd. Class A shares (Form 4)

Traded Sep 28, 2026 · Filed Sep 30, 2026

On Sep 28, 2026, Wang Xiaodong (Director, Chair, Scientific Advisory Brd) sold 31,028 Beone Medicines Ltd. Class A shares at an average US$364.79 for US$11.3M under a trading plan, leaving 0 shares. Filed Sep 30, 2026 (Form 4).

Sold
31,028 shares
Price
US$364.79 average (US$356.97 to US$367.23)
Value
US$11.3M
Holding after
0 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chair, Scientific Advisory Brd

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 28, 2026American Depositary SharesOption exercise31,028US$36.9031,028Direct
Sep 28, 2026American Depositary SharesSale160US$356.9730,868Direct
Sep 28, 2026American Depositary SharesSale120US$358.7130,748Direct
Sep 28, 2026American Depositary SharesSale40US$359.1630,708Direct
Sep 28, 2026American Depositary SharesSale2,241US$361.0528,467Direct
Sep 28, 2026American Depositary SharesSale4,239US$362.1724,228Direct
Sep 28, 2026American Depositary SharesSale3,499US$363.1020,729Direct
Sep 28, 2026American Depositary SharesSale3,419US$364.0717,310Direct
Sep 28, 2026American Depositary SharesSale2,047US$365.8515,263Direct
Sep 28, 2026American Depositary SharesSale14,525US$366.58738Direct
Sep 28, 2026American Depositary SharesSale738US$367.230Direct

Source

View original at SEC

Related